Comparing Semaglutide and Tirzepatide Uses Semaglutide has different indications, depending on the brand name medication: Wegovy: Weight loss, cardioprotection in patients with excess weight Ozempic: Glycemic control in patients with type 2 diabetes, cardioprotection/kidney protection in patients with type 2 diabetes and cardiovascular/kidney disease Rybelsus: Glycemic control in type 2 diabetes Tirzepatide is approved for the following, depending on the brand name medication: Zepbound: Weight loss, sleep apnea in adults with obesity Mounjaro: Glycemic control in patients with type 2 diabetes However, Ozempic and Mounjaro can also be prescribed for weight management off-label
Omega-3s: Taking fish oil with dinner can help prevent any fishy aftertaste and improves absorption of fat-soluble vitamins
Preclinical data in rodent models showed approximately 37% greater hepatic fat reduction versus tirzepatide-equivalent dosing, a finding cited in multiple human trial design rationales as justification for the Retatrutide vs Tirzepatide superiority hypothesis in hepatic metabolic disease contexts
Some patients report fatigue, dizziness, or headache, particularly during the initial weeks of treatment
Studies have found that about 5.6% of multi-dose medication vials, like semaglutide, develop bacterial growth over time
